ADVITOS products enable complex treatments in the field of multi-organ support to improve the survival chances of intensive care patients. Multi-organ failure (MOF) is one of the most difficult ...
Munich, Germany, 28.01.2022 (PresseBox) - ADVITOS enjoys a well-earned reputation in the field of medical technology on the back of its self-developed ADVOS procedure – the 4-in-1 organ support for ...
ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m€ financing round led by Crédit Mutuel Equity, with a co-investment from the EU EIC ...
Paid and presented by ADVITOS. The four-pronged effort of this medical technology is giving patients a better chance of recovery in the ICU. Innovations propelling medical technology into the future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results